Information about Bard IVC Filter Lawsuits from Lawyers Handling IVC Filter Lawsuits

No-Cost, No-Obligation Bard IVC Filter Lawsuit Review

IVC Filter Lawsuits

IVC Filters May Not Be Needed And Offer No Reduction In Mortality

Bard IVC Filter Lawsuits

The efficacy of IVC filters is being called into question by scientific studies while plaintiff lawyers focus on the potential catastrophic injuries caused by the device

Monday, September 27, 2021 - Juries in the upcoming Bard IVC filter lawsuits will rely on the testimony of plaintiff experts witnesses when trying to make sense of the complex science that underlies why IVC filters fail so often, and also the catastrophic injuries it can cause. The issue is whether to remove the device or not because it may trap so many blood clots that it becomes a potential source of blood clots down the road. There is no guarantee that a blood clot once trapped will stay trapped. The Expert Institute reports that more than 3000 plaintiffs have filed suit alleging that the device has caused them serious injury over and above the benefits that the company claims it provides. IVC filter lawyers are interviewing patients that have experienced complications requiring second, third, or more revision surgeries. Some patients have been told that retrieving all of the broken pieces would be impossible and that they must learn to live with the risk of instant death.

Several bellwether trials have concluded so far and the results, however, have been mixed. Several juries have found that the company provided an adequate warning of IVC filter complications to doctors and patients before they undertook the procedure. "C.R. Bard won its second IVC filter lawsuit on June 1, 2018. An Arizona jury found the company adequately warned doctors of risks and complications. Bard lost a $3.6 million verdict in the first trial earlier this year. The company faces more than 3,800 IVC filter lawsuits in Arizona federal court" according to DrugWatch.com. The successful plaintiff lawsuit involved Georgia resident Doris Jones who experienced arm pain and headaches five years after having the Bard Eclipse IVC filter implanted in 2010. Doctors determined that the filter had fractured and blocked her pulmonary artery, the vessel that carries life-giving blood and oxygen to and from the heart, according to DrugWatch. Not all of the IVC filter fragments could be retrieved. Pieces that remain, it is argued, pose a constant threat to her life.

Studies have concluded the device may not be needed. It appears that all the device does is delay the risks a blood clot patient faces. Studies published in credible, peer-reviewed publications indicate that the device`s benefits are questionable and may be unneeded. The American Journal of Medicine reports, "the vast majority of filters that are placed in patients with a pulmonary embolism may not reduce mortality," according to the Expert Institute. Other studies published by the Annals of Surgery and JAMA Internal Medicine claim essentially the same thing. CR Bard Inc. allegedly ignored reports of its IVC filter failures. According to the Expert Institute, " (The filter) punctured the vena cava or migrated out of their placed positions, causing metallic fragments to travel to the heart or lungs and cause embolization. Despite these warnings, Bard continued to sell its devices without warning patients and doctors about the defects."

More Recent IVC Filter Lawsuit News:

No-Cost, No-Obligation Bard IVC Filter Lawsuit Case Review for Persons or Families of Persons Who Suffered from Organ Damage, Severe Bleeding, Stroke, or Death

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.